Antileishmanial activity of 5-nitroindazole derivatives

BACKGROUND: Currently, there is no safe and effective vaccine against leishmaniasis and existing therapies are inadequate due to high toxicity, cost and decreased efficacy caused by the emergence of resistant parasite strains. Some indazole derivatives have shown in vitro and in vivo activity agains...

Descripción completa

Detalles Bibliográficos
Autores principales: Mollineda-Diogo, Niurka, Chaviano-Montes de Oca, Claudia Sissely, Sifontes-Rodríguez, Sergio, Espinosa-Buitrago, Teresa, Monzote-Fidalgo, Lianet, Meneses-Marcel, Alfredo, Morales-Helguera, Aliuska, Perez-Castillo, Yunierkis, Arán-Redó, Vicente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617274/
https://www.ncbi.nlm.nih.gov/pubmed/37915499
http://dx.doi.org/10.1177/20499361231208294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617274/
https://www.ncbi.nlm.nih.gov/pubmed/37915499
http://dx.doi.org/10.1177/20499361231208294

Ejemplares similares